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THE NEW RADIOBIOLOGY: RETURNING TO OUR ROOTS
Brant A. Ulsh, PhD, CHP  M.H. Chew and Associates
 In 2005, two expert advisory bodies examined the evidence on the effects of low doses
of ionizing radiation. The U.S. National Research Council concluded that current scien-
tific evidence is consistent with the linear no-threshold dose-response relationship
(NRCNA 2005) while the French National Academies of Science and Medicine conclud-
ed the opposite (Aurengo et al. 2005). These contradictory conclusions may stem in part
from an emphasis on epidemiological data (a “top down” approach) versus an emphasis
on biological mechanisms (a “bottom up” approach). In this paper, the strengths and lim-
itations of the top down and bottom up approaches are discussed, and proposals for
strengthening and reconciling them are suggested. The past seven years since these two
reports were published have yielded increasing evidence of nonlinear responses of bio-
logical systems to low radiation doses delivered at low dose-rates. This growing body of evi-
dence is casting ever more doubt on the extrapolation of risks observed at high doses and
dose-rates to estimate risks associated with typical environmental and occupational expo-
sures. This paper compares current evidence on low dose, low dose-rate effects against
objective criteria of causation. Finally, some questions for a post-LNT world are posed.
Key terms: linear no-threshold hypothesis, hormesis, cancer
INTRODUCTION
“In the space of one hundred and seventy-six years the Lower
Mississippi has shortened itself two hundred and forty-two miles. That
is an average of a trifle over one mile and a third per year. Therefore,
any calm person, who is not blind or idiotic, can see that in the Old
Oolitic Silurian Period, just a million years ago next November, the
Lower Mississippi River was upwards of one million three hundred
thousand miles long, and stuck out over the Gulf of Mexico like a fish-
ing-rod. And by the same token any person can see that seven hun-
dred and forty-two years from now the Lower Mississippi will be only
a mile and three-quarters long, and Cairo and New Orleans will have
joined their streets together, and be plodding comfortably along
under a single mayor and a mutual board of aldermen. There is some-
thing fascinating about science. One gets such wholesale returns of
conjecture out of such a trifling investment of fact.”
—Mark Twain - Life on the Mississippi (Twain 1883)
Brant A. Ulsh, PhD, CHP, Principal Health Physicist, M.H. Chew and Associates,
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Current radiation protection philosophy is based on the linear no-
threshold (LNT) theory. This theory postulates that any dose of ionizing
radiation, no matter how small, causes a finite increase in cancer risk. The
LNT theory does not predict any qualitative differences in effects
between low doses delivered at low dose-rates (LDDR) and high doses
delivered at high dose-rates (HDDR), it does not allow for the possibility
that LDDR may decrease risks, and it does not account for nonlinear
modifiers of risk. While a majority of radiation scientists believe a thresh-
old model more accurately describes LDDR risks than the LNT model
(Silva et al. 2007; Jenkins-Smith et al. 2009), the opinions expressed by
expert advisory bodies are divided. Based in part on epidemiological evi-
dence, the U.S. National Research Council’s BEIR VII Committee con-
cluded, “…current scientific evidence is consistent with the hypothesis
that there is a linear, no-threshold dose-response relationship between
exposure to ionizing radiation and the development of cancer in
humans” (NRCNA 2005). On the other hand, based in part on radiobio-
logical evidence, the French National Academies of Science and
Medicine concluded, “…it is not justified to use the linear no-threshold
relationship to assess the carcinogenic risk of low doses observations
made for doses from 0.2 to 5 Sv since for the same dose increment the
biological effectiveness varies as a function of total dose and dose rate”
(Aurengo et al. 2005).
Other authors have written authoritative histories of how the LNT
came to be the current foundation of radiation protection philosophy
(Taylor 1980; Kathren 1996; Jones 2005; Calabrese 2009), and it is not the
purpose of this paper to recount the details of this history. The important
point to note for the current discussion is that the LNT theory has not
always enjoyed the dominant status that it has today. Indeed, during the
first three decades of radiation regulation, protection standards were
based on the philosophy that there was a threshold dose which must be
exceeded to induce harmful effects. It was only in the years after World
War II that a no-threshold assumption began to take hold. The shift from
a threshold based view of LDDR effects to a LNT view has been contro-
versial from the very beginning. This change in regulatory philosophy
was due in part to a variety of non-scientific influences (Taylor 1980), and
to the advocacy of the LNT theory by H. J. Muller and other like-minded
geneticists, in spite of evidence contradicting low dose linearity
(Calabrese 2011, 2012). Over the years the topic of biological effects and
risks of low doses of ionizing radiation, and how these should be calcu-
lated, has developed into the longest running debate in the radiation sci-
ences.
This paper examines the current insights from radiation biology and
epidemiology, in particular the body of research from these fields focus-
ing on the biological effects of occupationally and environmentally rele-
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vant doses of radiation (i.e. typically LDDR). This body of research is crit-
ically evaluated against the criteria of causation laid out in a seminal and
highly influential classic paper from occupational medicine (Hill 1965)
that describes how causation may be differentiated from association when
determining the relationship, if any, between environmental factors (e.g.
ionizing radiation), and disease (e.g. cancer).
RETURNING TO OUR SCIENTIFIC ROOTS
The starting assumption, or null hypothesis, in epidemiological (or
biological) studies is that there is no association between the putative
causative agent (e.g. exposure to ionizing radiation) and the observed
effect (e.g. cancer) (Rothman et al. 1998). Should the evidence prove suf-
ficient to reject the null hypothesis in favor of an alternative hypothesis
(e.g. radiation exposure increases the incidence of cancer in linear pro-
portion to dose), the alternative is accepted in place of the null. It can
and has been argued that the lack of an observed association in epi-
demiological studies between radiation and cancer, especially in popula-
tions exposed to LDDR, should not be interpreted as evidence that such
an association does not in fact exist (UNSCEAR 2000; Preston et al. 2003;
ICRP 2005). It is certainly true that one can never conclude that there is
absolutely no association, because it can always be argued that a vanish-
ingly weak association may exist but be so small in magnitude that it is
undetectable, especially in studies with limited statistical power. However,
it is scientifically unsound to extend this argument as the basis for a pre-
sumption that carcinogenic risk is increased by LDDR radiation expo-
sure, even at doses and dose-rates far below where such risks have actual-
ly been observed, simply because an absolute absence of any association
whatsoever cannot be demonstrated. This line of reasoning inappropri-
ately shifts the burden of proof to the null hypothesis (no effect), and cre-
ates a well-known logical fallacy (Walton 1999) because it is impossible to
prove a negative assertion. To assert that LDDR increases cancer risk sim-
ply because it is impossible to prove that it does not is an untestable argu-
ment, and therefore it is contrary to accepted scientific method (Popper
1959). The burden of proof is appropriately placed on the alternative
hypotheses predicted by the LNT theory. The same burden of proof must
be borne by any other alternative hypotheses e.g. hormesis, supra-lineari-
ty, etc.
Advocating for any particular alternative hypothesis and defending it
against challenges is diametrically opposed to the scientific method.
Rather, the responsibility of scientists is to vigorously attempt to disprove
hypotheses predicted by particular theories. It is only by failing to dis-
prove the hypotheses of a given theory after repeated attempts that it
gains some measure of credibility. It is worth remembering that no theo-
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ry – whether it is hormesis, LNT, or any other – can ever be proved. It can
only fail to be disproved (Popper 1959).
HILL’S CRITERIA OF CAUSATION
In 1965, Sir Austin Bradford Hill delivered an address to the British
Royal Society of Medicine’s newly formed Section of Occupational
Medicine (Hill 1965). The purpose of Hill’s address was to address the
questions,
1. “How in the first place do we detect these relationships between sick-
ness, injury and conditions of work”?
2. “How do we determine what are physical, chemical and psychological
hazards of occupation, and in particular those that are rare and not
easily recognized”?
3. “…we see that in the event B is associated with the environmental fea-
ture A, that, to take a specific example, some form of respiratory ill-
ness is associated with a dust in the environment. In what circum-
stances can we pass from this observed association to a verdict of
causation? Upon what basis should we proceed to do so?”
Hill proceeded to lay out several criteria by which causation could be
distinguished from simple associations between factors in the occupa-
tional environment and adverse health impacts. The current paper eval-
uates the body of evidence related to LDDR and carcinogenesis against
Hill’s criteria. Hill was careful to note that he was describing a weight-of-
the-evidence approach, stating,
“Here then are nine different viewpoints from all of which we should
study association before we cry causation. What I do not believe – and
this has been suggested – is that we can usefully lay down some hard-
and-fast rules of evidence that must be obeyed before we accept cause
and effect. None of my nine viewpoints can bring indisputable evi-
dence for or against the cause-and-effect hypothesis and none can be
required as a sine qua non. What they can do, with greater or less
strength, is to help us to make up our minds on the fundamental
question – is there any other way of explaining the set of facts before
us, is there any other answer equally, or more, likely than cause and
effect?” (Hill 1965)
Before proceeding with this evaluation, it is worth discussing some of
the underlying premises. First, an evaluation via Hill’s criteria of whether
or not LDDR causes cancer presupposes that an association between
LDDR and cancer has been observed. This is a very debatable supposi-
tion. While very few scientists would argue against an association between
B. A. Ulsh
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HDDR exposures and increases in cancer risk, there is a growing body of
radiobiological evidence that the biological mechanisms initiated in
response to LDDR are qualitatively different than those initiated in
response to HDDR (Amundson et al. 2003; Ulsh 2010; Neumaier et al.
2012). This calls into question the logic of treating LDDR as a lesser
degree of HDDR, and extrapolating from HDDR effects which can be
observed, to predict effects of LDDR which are not in evidence. To pro-
ceed with the current evaluation, suffice it to say that at least a few epi-
demiological studies claim to observe an association between LDDR and
cancer. Given these claims, how strong is the evidence that LDDR causes
cancer? This is the subject of the current paper.
1. STRENGTH
The first of Hill’s criteria is the strength of the association. Stronger
associations (i.e. larger effects per unit dose) are more convincing than
weaker ones. Though some have claimed adverse health risks from acute
doses as low as 10 mGy (Brenner et al. 2003), the general consensus is that
the lowest dose at which increases in cancer risk are consistently observed
is approximately 50-100 mGy for acute doses, and 100 mGy for chronic
exposures (HPS 2010). Given that the annual background dose-rate in
the United States is approximately 6.2 mSv (NCRP 2009), this means that
chronic doses even 16 times higher than background fail to cause an
observable increase in cancer risk.
As an example, consider the most widely cited study of a radiation
exposed population, the Life Span Study (LSS) of the survivors of the
atomic bombings in Japan. Studies of this cohort form much of the basis
for contemporary radiation standards. Among the 105,427 Japanese sur-
vivors of the atomic bombings of Hiroshima and Nagasaki studied in the
LSS, there were 17,488 solid cancers as of 1998 (Preston et al. 2007). This
compares with an expectation of 16,595 solid cancers in the absence of
radiation exposure in this population, yielding an excess of 893 solid can-
cers which the authors attributed to radiation exposure. Roughly speak-
ing, this is an overall excess of (893/16,595) ≈ 5% in this population.
Compare this with the health impact of smoking. According to the U.S.
Surgeon General, smoking causes 443,000 deaths in the United States
each year (Benjamin 2010). That means 20% of the total number of
deaths occurring in the U.S. each year are attributable to cigarette smok-
ing. This comparison is presented here simply to demonstrate that ioniz-
ing radiation, even at high doses and dose-rates, is a relatively weak car-
cinogen.
2. CONSISTENCY
This criterion is generally defined by Hill as repeatability, or general-
ity. Associations are more convincing if they have been observed on
The New Radiobiology: Returning to Our Roots
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numerous occasions, under different circumstances, and by numerous
researchers. Ionizing radiation is one of the most exhaustively studied
and easily measured carcinogens, and thousands of studies of occupa-
tional and environmental exposure situations have been conducted.
Findings on LDDR exposures and cancer risk have consistently failed to
show an association with cancer, with a few claimed exceptions. Only a
few epidemiological studies have claimed to observe an association
between LDDR and increased cancer risk e.g. (Cardis et al. 2005;
Krestinina et al. 2005).
Extrapolation from higher doses to estimate low doses is employed
because epidemiological studies of occupational cohorts exposed to ion-
izing radiation frequently reveal cancer rates that are below those of the
general population, and/or no dose-response relationship is observed
when exposed workers are compared to unexposed workers in the same
cohort. This is almost always axiomatically attributed to the healthy work-
er effect (Monson 1986), without any consideration of plausible alterna-
tive hypotheses (e.g. radiation hormesis) (Fornalski et al. 2010). This is a
discussion for another paper.
The most parsimonious explanation for the rarity of epidemiological
observations of a change in risk at low doses is that LDDR has no effect
on risk. Alternatively, this may simply reflect a lack of power to detect
effects at low doses and dose rates, even if such effects exist. The inabili-
ty to distinguish between these two alternatives is a fundamental limita-
tion of the top-down, epidemiological approach (Land 1980; Brenner et
al. 2003). Accounting for confounding factors (e.g. smoking, excessive
alcohol consumption, obesity, etc.) can also be challenging. The result is
that epidemiological approaches are limited in their ability to provide
support for one hypothesis of LDDR risks (e.g. LNT) and exclude com-
peting alternative hypotheses (e.g. threshold, hormetic, or supra-linear
dose responses) at the environmental and occupational doses and dose-
rates with which we are typically concerned. Furthermore, most epidemi-
ological studies are designed to detect only increases in risk, and they
ignore the possibility of radiation-induced suppression of cancer in spite
of a wealth of biological evidence to suggest this as a possibility. These
design characteristics include reporting excess relative risk (ERR) which
does not account for risk decrements, assigning individuals exposed to
low, possibly protective doses as the control group (which artificially
inflates risk estimates), discarding significant fractions of the received
dose (i.e lagging), even though this is inconsistent with the LNT theory,
binning doses over wide intervals [which camouflages departures from
linearity (Scott 2011)], and including only recorded external dose when
subjects were potentially exposed to doses from internally deposited
radionuclides as well, or vice versa (e.g. almost all uranium miner studies).
These limitations must be balanced against the inherent strength of epi-
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demiological studies - they directly observe the endpoint of interest (i.e.
frequency of cancer, or some other health effect in exposed human pop-
ulations), and no extrapolation from putative surrogate endpoints of risk
(e.g. chromosome aberrations or mutations) is required. However, it is
worth noting that some biological studies show that LDDR delays the
onset of cancer, rather than changing the frequency of cancer e.g.
(Mitchel et al. 1999), and most radiation epidemiology studies do not
explicitly look for this effect.
To get a more complete picture of the effects of LDDR, we must turn
to radiation biology to fill in some of the missing pieces. While radiation
epidemiology focuses on the top of the biological hierarchy (i.e. human
populations), radiation biology studies take a bottom-up approach, typi-
cally focusing on lower levels of biological organization – from biologi-
cally relevant molecules (e.g. DNA) to individual organisms (e.g. mice).
The fundamental strengths of this approach are that exquisite control of
potential confounding factors can be exercised and high precision and
power to detect small effects can be achieved. These strengths must be
balanced against the fundamental limitation of radiation biological
approaches – relating surrogate endpoints (e.g. DNA double strand
breaks, chromosome aberrations, mutations, DNA repair foci, etc.) to
effects we really care about (e.g. cancer) is not straightforward.
Extrapolating risks from species typically studied in the laboratory (e.g.
mice, rats, etc.) to humans adds another layer of uncertainty (NCRP
2005).
Radiation biological studies have frequently observed non-linear
dose-response relationships between LDDR and various biological end-
points. So how general are these nonlinear phenomena? If they are “bou-
tique” phenomena i.e. they are only observed in very specific and unreal-
istic situations created in the laboratory, then they are likely to have lim-
ited applicability to real-world situations. On the other hand, if they are
widely observed in various species, in response to various stressors, and
under different conditions, the case for causation would be bolstered.
Consider, for example, adaptive responses. This phenomenon has been
observed in algae (Boreham et al. 1993), yeast (Boreham et al. 1994),
insects (Schappi-Buchi 1994), frogs (Audette-Stuart et al. 2011), mice
(Mitchel et al. 1999; Mitchel et al. 2002; Boreham et al. 2006; Day et al.
2007; Singh et al. 2011), rabbits (Liu et al. 1992; Cai et al. 1996; Flores et
al. 1996), cows (Flores et al. 1996), deer (Ulsh et al. 2004), fish (Smith et
al. 2011) and humans (Broome et al. 2002).
The generality of hormesis has also been questioned (Thayer et al.
2005), based in part on the frequency of this dose-response phenome-
non, and a putative assumption that such responses are universally bene-
ficial. The more than 1250 references cited in (Luckey 1980), the more
than 1000 references cited in (Luckey 1991), and other broad evaluations
The New Radiobiology: Returning to Our Roots
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of the frequency of hormetic dose-responses (Calabrese et al. 2006) offer
a certain level of confidence that this is a widely observed phenomenon.
Hormesis has been observed in disparate fields including toxicology, bio-
medical sciences, and psychology, in addition to radiation biology
(Calabrese 2008). Radiation hormesis is typically observed over an acute
dose range spanning roughly a few mGy up to several tens of mGy, and
up to a few hundreds of mGy for low dose-rates, depending on the end-
point considered. On the other hand, a linear dose-response is typically
observed at higher acute doses – from several tens of mGy up to a few
hundred mGy. While HDDR exposures indisputably increase cancer risk,
LDDR exposures consistently fail to do so even at doses 5-10 times back-
ground, and LDDR frequently decreases the frequency of surrogate end-
points associated with carcinogenesis.
3. SPECIFICITY
The importance of this particular criterion should not be overesti-
mated. As Hill stated, “…if specificity exists we may be able to draw con-
clusions without hesitation; if it is not apparent, we are not thereby nec-
essarily left sitting irresolutely on the fence”. The question is, are there
unique, specific effects that appear to be associated with the putative
causative agent?
While the relationship between radiation and cancer is not as specif-
ic as, for example, asbestos and mesothelioma – there are many other
causes of cancer - there is a well-established relationship between HDDR
and some (but not all) forms of cancer. Comprehensive reviews of the
association between ionizing radiation exposure and various site-specific
cancers have been published (Boice et al. 2006; UNSCEAR 2006; Mettler
et al. 2008), and there is reasonable consensus that some forms of cancer
are associated with ionizing radiation exposure, particularly HDDR, and
others are not. There is consistent or strong evidence of an association
between HDDR and cancers of the female breast, colon, esophagus,
leukemia (excluding chronic lymphocytic leukemia), liver, lung, ovary,
salivary gland, stomach, and urinary bladder. On the other hand, there is
little or no consistent evidence of an association between HDDR and
chronic lymphocytic leukemia, Hodgkin’s lymphoma, non-Hodgkin’s
lymphoma, multiple myeloma or cancers of the gall bladder, larynx, male
genitalia, oral cavity, pancreas, pharynx, prostate, skin (squamous cell
carcinoma and malignant melanoma), small intestine, and uterus. The
evidence for radiogenicity of bone and kidney cancers is limited to high
doses characteristic of radiotherapy and injection of bone-seeking a emit-
ters. There is little evidence suggesting a relationship at low to moderate
doses typical of the occupational or environmental exposures. In the case
of brain cancer, there is evidence of radiogenicity only for benign tumors,
especially meningioma and neurilemmoma. There is little evidence of an
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association between ionizing radiation exposure and malignant brain
tumors. There is little evidence of radiogenicity of rectal cancer at low to
moderate environmental or occupational doses. The evidence for an
association is stronger at very high doses (tens of Gy). The evidence for
radiogenicity of basal cell carcinoma (BCC) of the skin is more compli-
cated. There is strong evidence of an association between basal cell carci-
noma and ionizing radiation exposure received at young ages. The
strength of association with exposures declines with increasing age. The
evidence of radiogenicity of thyroid cancer is similarly limited largely to
populations exposed as children. In summary, while there is evidence of
associations between HDDR and some specific forms of cancer, the same
cannot be said of LDDR exposures.
4. TEMPORALITY
Is the observed effect preceded in time by exposure to the putative
causative agent? Hill notes that this criterion might be especially impor-
tant in diseases of slow development. If essence, this criterion deals with
identifying whether the environmental factor of interest is the cause of
the adverse health effects, or the result. It is certainly the case that HDDR
causes subsequent peaks in cancer incidence years after the exposure
occurred (e.g. in the Japanese survivors of the atomic bombs), and this
speaks directly to the temporality criterion. One obvious application of
this criterion would be in evaluating evidence from medically exposed
cohorts e.g. is any subsequent increase in cancer incidence a result of the
medical exposure, or does an underlying susceptibility to cancer make
medical exposure more likely. It is less obvious how any health effect
might make LDDR exposure more likely, therefore this criterion would
not seem to be particularly informative for this situation.
5. BIOLOGICAL GRADIENT
Hill asserts that demonstration of a dose-response relationship, par-
ticularly a simple relationship (e.g. a linear, no-threshold) greatly adds to
the weight of the evidence in favor of a causative relationship. The prob-
lem, as discussed throughout this paper, is that LDDR exposures appear
to elicit qualitatively distinct responses from those associated with HDDR.
Very low doses of radiation exhibit nonlinear dose-responses. One of the
defenses of the LNT theory is that it is simple. But simplicity at the
expense of realism is no bargain. While a simple, LNT dose-response
would be more convenient and would strengthen the case for LDDR cau-
sation of cancer, LDDR exposures in fact appear to result in complex and
nonlinear responses.
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6. PLAUSIBILITY
Causation is more convincingly indicated when observed associations
e.g. in epidemiology studies, are consistent with biological knowledge.
Hill cautions that this criterion cannot be demanded as a condition of
causation, as a lack of a plausible explanation may simply reflect the
shortcomings of the state of biological knowledge. But this criterion rep-
resents one of the most significant challenges to the LNT model. The
LNT theory is predicated on the notion that since radiation damages cells
in a fashion linearly dependent on dose, subsequent carcinogenesis
should also be linearly dependent on dose (NCRP 2001). However, this
theory takes no account of intervening biological mechanisms for main-
taining homeostasis, many of which have been shown to be nonlinear
with dose. As evidence continues to accumulate that biological responses
to LDDR are nonlinear, the plausibility of the LNT theory continues to
erode.
7. COHERENCE
Interpretation of epidemiological data should not conflict with the
known natural history of the disease in question. For example, the rise in
lung cancer rates with the smoking rate supported the conclusion of a
causative relationship. Due in no small part to the effectiveness of a safe-
ty culture in nuclear and radiation applications, HDDR is generally limit-
ed to very discrete situations (e.g. radiotherapy, nuclear warfare, etc.). It
would be difficult to determine the concordance between cancer rates in
general, and HDDR exposures in particular since only small, discrete seg-
ments of the population are exposed to HDDR. On the other hand, pop-
ulation exposures to generally low-dose, but high dose-rate exposures in
medical applications is increasing (NCRP 2009), and there is much
debate about the risks, if any, that this poses (Scott et al. 2008; Brenner et
al. 2011). It will be very informative to see whether or not an increase in
cancer frequency - predicted by the LNT theory – actually materializes as
a result of increased medical exposures among the general population.
The lack of such an increase would seem to put the LNT theory at odds
with the coherence criterion.
8. EXPERIMENT
Experimental evidence greatly strengthens the case for causation.
There is a solid body of experimental evidence showing that HDDR, but
not LDDR, increases the frequency of several experimental endpoints
thought to be involved in the chain of events leading to eventual car-
cinogenesis. The frequency of chromosome aberrations as measured by
chromosome painting techniques is clearly increased by doses of 1 Gy or
higher delivered at high dose-rates (1.3 Gy min-1) (Loucas et al. 2001).
B. A. Ulsh
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Even at these high doses and dose-rates, nonlinear dose-response curves
were observed. However, while this endpoint shows great promise,
improvements in technique would enhance its utility for detecting LDDR
effects (Tucker 2008). Studies of cell transformation reveal that HDDR
(doses greater than 100-200 mGy delivered at dose-rates of 30-3000 mGy
min-1) increases transformation frequency, while LDDR reduces transfor-
mation frequency below spontaneous levels i.e. this model system follows
a typical hormetic dose-response curve (Redpath 2006; Redpath et al.
2007; Elmore et al. 2008). Radiation-induced mutations have also been
shown to follow nonlinear, hormetic dose-response models (Kelsey et al.
1991; Zeng et al. 2006; Day et al. 2007). Cells exposed to LDDR frequent-
ly undergo apoptosis, and LDDR also induces apoptosis in spontaneous-
ly damaged cells (Bauer 2007), suggesting a hormetic mechanism. A vari-
ety of immune system parameters associated with cancer suppression are
improved by LDDR, providing another hormetic mechanism
(Nowosielska et al. 2006; Liu 2007). These are just a few examples of
recent radiobiological evidence that is increasingly inconsistent with the
LNT theory, and frequently reveal threshold or hormetic responses to
LDDR exposures. Reviews of additional examples have been published by
many authors (Cohen 2008; Scott 2008a; Averbeck 2009; Tubiana et al.
2009; Sanders 2010; Ulsh 2010).
9. ANALOGY
The analogy criterion suggests that the weight of the evidence for cau-
sation is strengthened if other agents have been identified that induce a
response similar to that observed following exposure to the agent in ques-
tion. There are many other chemical and physical agents that induce an
adaptive response and/or nonlinear dose-responses similar to that
observed following LDDR exposure. Chemically-induced effects fre-
quently follow a hormetic or threshold dose-response (Calabrese et al.
2006; Calabrese et al. 2008; Calabrese et al. 2011). Hyperthermia also
induces an adaptive response similar to that induced by LDDR (Boreham
et al. 1997). Exposure to low levels of some metals induces a radioadap-
tive response (Cai et al. 1996; Cai et al. 2000; Cai et al. 2004), as does expo-
sure to low levels of hydrogen peroxide (Dominguez et al. 1993; Flores et
al. 1996). Indeed, in studies with study designs capable of detecting it,
hormesis is a relatively commonly encountered dose-response relation-
ship across diverse environmental agents (Calabrese 2009), while low-
dose linearity is rarely observed but rather is frequently an artifact of
extrapolation from high doses to low.
STRONG INFERENCE
By combining the insights from top-down, epidemiology approaches
and bottom-up, biology approaches, a more complete picture of LDDR
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effects based on the total weight of the combined evidence can be gained
(Clarke 1999). Hill’s criteria (Hill 1965) provide an objective and organ-
ized framework for evaluating the weight of the evidence on cancer cau-
sation by LDDR. This evaluation has revealed that the case for LDDR cau-
sation of cancer fail to satisfy these objective criteria, while hormesis and
threshold models have a much more compelling weight of the evidence
behind them.
In his seminal 1964 article, Platt observed that some fields of science
were advancing rapidly, while others seemed to stagnate (Platt 1964). He
attributed the success of certain fields (e.g. particle physics and molecular
biology) to the rigorous strategy of testing multiple hypotheses, and iter-
atively designing experiments to exclude particular hypotheses – a strate-
gy he referred to as “strong inference”. On the other hand, the lack of
progress in other fields was a result of failure to continuously and itera-
tively test hypotheses and a retreat to the tedium of repeating similar
experiments over and over again without any thought to advancing the
state of the knowledge.
Unfortunately, the LDDR debate frequently devolves into warring
camps of scientists advocating particular hypotheses (e.g. LNT, threshold,
or hormesis), and accusations of selective data interpretation fly from all
sides. Advocacy of particular theories has inappropriately supplanted
healthy scientific skepticism, hypothesis testing, and robust application of
the scientific method. The main purposes of this paper were to evaluate
the current state of knowledge on LDDR effects, to issue a call for a
return to “strong inference” (Platt 1964) and an abandonment of advo-
cacy of particular theories of LDDR effects by the scientific community.
Indeed, advocating any theory, instead of vigorously attempting to dis-
prove it, is contrary to the scientific method and leads inevitably to the
stalemate and acrimony that characterizes the current state of LDDR sci-
ences. It is time to move beyond the LNT debate.
QUESTIONS FOR A POST-LNT ERA
Once a consensus that biological responses to LDDR are nonlinear is
widely acknowledged, the scientific community can refocus on more pro-
ductive avenues of inquiry instead of devoting its collective efforts and
resources on trying to make nonlinear data fit LNT theory. Some ques-
tions that could be addressed include:
1) What is the relevance to organism and population level effects of the
in vitro nonlinear phenomena (e.g. induced hyper-radiosensitivity, ge-
nomic instability, bystander effects, adaptive response) that appear to
dominate biological responses to low dose, low dose-rate exposures?
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2) How general are in vitro nonlinear phenomena? Are there conditions
(e.g. exposure protocols, cell lines, cell cycle status, etc.) where these
phenomena are not observed?
3) Do nonlinear factors such as bystander effects and induced genomic
instability increase or decrease cancer risk? Or is the situation even
more complex than this question suggests? How relevant are these
phenomena in in vivo?
4) Are alternative dose-responses (e.g. threshold, hormetic, supra-linear,
etc.) inconsistent with epidemiological studies of populations
exposed to low dose, low dose-rate exposures? If epidemiological
studies lack the statistical power to select one alternative hypothesis
and exclude plausible competing hypotheses, then the null hypothe-
sis stands (e.g. no detectable effects). If this is the case, over what
range of doses and dose-rates are effects (“positive” or “negative”)
observed? How consistent are these ranges across different end-
points, cell-types, tissues, and organisms?
5) Epidemiological practices such as dose-lagging, where doses received
for a period immediately prior to the diagnosis of cancer are disre-
garded, should be re-examined in light of current mechanistic knowl-
edge. Lagging has been justified on the basis of observations that can-
cers tended to appear in waves some years after discrete, acute expo-
sures (e.g. in the LSS cohort). But does lagging make sense in the
context of LDDR, where activation of various biological defense
mechanisms is the norm in the hours following exposure or even
while chronic exposure is still occurring? Throwing away dose tends
to inflate estimates of risk per unit dose, and to obscure the existence
of thresholds.
6) What interactions (e.g. synergism, antagonism, etc.), if any, occur
between LDDR radiation and other common environmental stressors
(e.g. hyperthermia, heavy metals, organic toxicants, etc.)?
7) There is some suggestion that LDDR can actually prevent lung can-
cer among high risk groups (Scott 2008b; Scott et al. 2009). There is
also evidence that LDDR can improve cancer control rates
(Sakamoto et al. 1997). The prophylactic effect of LDDR could have
clinical significance, and should be investigated.
8) There is also evidence that radon can inhibit inflammation (Franke
et al. 2000; Kataoka et al. 2012), and protect against hepatic and renal
damage (Kataoka et al. 2011). The clinical efficacy of radon therapy
for such conditions should be considered against a realistic and accu-
rate (i.e. not derived from extrapolation of HDDR exposures) assess-
ment of any risks from the radon exposures involved in such treat-
ments.
9) What radiation protection strategies make sense in a post-LNT world?
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These are just a few of the relevant questions we could be addressing
if we collectively decided not to cling to increasingly dubious and outdat-
ed theories of linearity. Explicit experiments designed to narrow the field
of plausible alternative hypotheses should be designed and rigorously
tested. Moving beyond the LNT debate promises to open exciting and
productive avenues of scientific research and provide defensible strate-
gies for the protection of workers, the public, and the environment.
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